fda warning letter compounding semaglutide news warns about safety of 'off-brand' versions of Ozempic, Wegovy July 29, 2024: FDA issued

With everyone online selling GLP-1s, Spencer Nadolsky, the medical director at Weight Watchers, wrote on X earlier this year, What will you do to be different? In another post, he wrote: Youre going to have to come up with a different value proposition beyond access to these medicines. Hims executives appear to be cashing out while they can

However, healthcare providers may prescribe the medication off-label for patients when medically appropriate

"You're seeing in the market just a tremendous boom of protein-infused products, whether it's cereals or snacks or drinks or bars," Furman said

However, tirzepatide is newer and individual responses vary